Primary Diffuse Large B Cell Lymphoma of the Bladder.
10.5045/kjh.2009.44.2.104
- Author:
Seon Kyeong KIM
1
;
Mi Hyun KIM
;
Naria LEE
;
Donghyuk CHA
;
Hyojeong KIM
;
Young Jin CHOI
;
Joo Seop CHUNG
;
Goon Jae CHO
Author Information
1. Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea. porori701@hanmail.net
- Publication Type:Case Report
- Keywords:
Urinary bladder;
Primary;
Diffuse large B cell lymphoma
- MeSH:
Aged;
Antibodies, Monoclonal, Murine-Derived;
Cystoscopy;
Doxorubicin;
Dysuria;
Humans;
Lymphoma;
Lymphoma, B-Cell;
Prognosis;
Rare Diseases;
Urinary Bladder;
Vincristine;
Rituximab
- From:Korean Journal of Hematology
2009;44(2):104-107
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Primary malignant lymphoma of the urinary bladder is a rare disease, and it accounts for only 0.2% of all the cases of extranodal lymphoma. The prognosis of primary bladder lymphoma has been favorable, with many patients being alive and well several years after treatment. We report here on a case of primary diffuse large B cell lymphoma of the urinary bladder in a 75-year-old man patient who presented with a one-month history of persistent dysuria. The abdominal CT revealed a mass at the posterior wall of the urinary bladder. The tissue obtained by transurethral cystoscopy showed an atypical lymphoid proliferation, which was consistent with diffuse large B cell lymphoma. The patient received systemic chemotherapy of rituximab and CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) and he achieved a significant partial remission.
